BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 13, 2002
View Archived Issues
Novel HIV integrase inhibitors in early development at Shionogi
Read More
Taisho claims preparation and use of two series of VEGF antagonists
Read More
Urokinase inhibitors with utility in cancer covered by Pentapharm patent
Read More
Novel AGE-breaking agents prepared and tested at Torrent
Read More
New modulators of chemokine receptors under study at AstraZeneca
Read More
Pfizer announces approval of Lipitor for use in children
Read More
Altana researchers identify novel tryptase inhibitors for asthma and other respiratory disorders
Read More
New PDE5 inhibitors in early development at Pfizer
Read More
Merck scientists study antidiabetic biguanide compounds
Read More
Update of PVAC treatment program for psoriasis
Read More
Preclinical antitumor activity of the anti-CD80 antibody IDEC-114
Read More
Effects of new Na+ channel blocker in rat pain models
Read More
T-588 protects rats against facial motoneuron injury
Read More
Intrathecal CGX-1007 protects against ischemic brain injury with extended therapeutic window
Read More
Improvement in memory, hippocampal apoptosis in AD rats treated with ibudilast
Read More
Cannabis-based medicine advances to phase II trials in patients undergoing chemotherapy
Read More
New, orally active NS3 protease inhibitor effective and safe in patients with chronic HCV infection
Read More
Targeted Genetics presents promising preclinical data from hemophilia program
Read More
CRF1 antagonist assessed in animal models of anxiety and depression
Read More
Initiation of phase III trial of eptifibatide in heart attack
Read More
F-97013-GD: a potent, orally active atypical antipsychotic agent
Read More
Phase III clinical data demonstrate efficacy of RU-0211 in treating occasional constipation
Read More
Baxter to acquire Epic Therapeutics
Read More
Health Canada approves irbesartan for diabetic renal disease
Read More
Positive results from TA-1790 erectile dysfunction study
Read More
Safety study completed for inhaled form of epinephrine
Read More
Human interferon beta gene therapy with selective activity against RCC
Read More